Andrew House

Andrew House

Principal Investigator

Biography

Dr. Andrew House is a clinical epidemiologist and nephrologist specializing in the design and analysis of clinical trials in acute kidney injury, chronic kidney disease, hemodialysis, and transplantation, with particular expertise in cardiorenal syndromes and tuberous sclerosis complex.

Active studies

0 listed

No active studies currently linked to this researcher.

Publications (last 3 years)

16 found
20257 items

Correction: Clinical management and burden of cytomegalovirus in D+/R-Kidney transplant recipients in Canada.

Gill J, House AA, Chagla Z, Tchervenkov J, Kim SJ, Vinson A, Cervera C, Keown PA, Sun SLW, Khoury C, Ghakis C

Front Immunol • 2025

Clinical management and burden of cytomegalovirus in D+/R-Kidney transplant recipients in Canada.

Gill J, House AA, Chagla Z, Tchervenkov J, Kim SJ, Vinson A, Cervera C, Keown PA, Sun SLW, Khoury C, Ghakis C

Front Immunol • 2025

Renal cell carcinoma with fibromyomatous stroma (RCC FMS) and with hemangioblastoma-like areas is part of the RCC FMS spectrum in patients with tuberous sclerosis complex.

Baranova K, Houpt JA, Arnold D, House AA, Lockau L, Ninivirta L, Pautler S, Chen H, Moussa M, Saleeb R, Gomez JA, Yilmaz A, Siadat F, Box A, Mahoney DJ, Zemp FJ, Gabril M, Trpkov K

Histopathology • 2025

Genetic Testing in Adults over 50 Years with Chronic Kidney Disease: Diagnostic Yield and Clinical Implications in a Specialized Kidney Genetics Clinic.

Schott C, Alajmi M, Bukhari M, Relouw S, Wang J, McIntyre AD, Baker C, Colaiacovo S, Campagnolo C, Almada Offerni G, Blake PG, Chiu M, Cowan A, Garg AX, Gunaratnam L, House AA, Huang SS, Iyer H, Jain AK, Jevnikar AM, Johnson J, Lotfy K, Moist L, Rehman F, Roshanov PS, Sultan N, Weir MA, Basharat P, Florendo-Cumbermack A, Khan T, Thain J, Kidd K, Kmoch S, Bleyer AJ, Bhangu J, Hegele RA, Connaughton DM

Genes (Basel) • 2025

The Current State of Care for Tuberous Sclerosis Complex in Canada.

Whitney R, Nouri MN, Sham L, Muir K, Andrade AV, Connolly MB, Donner EJ, Evanochko C, Flinn J, House AA, Kim RH, Kowal C, Major P, Teixeira Marques P, Suller-Marti A, Trinari E, Valcic M, Wilbur C, Zak M, Keezer MR

Can J Neurol Sci • 2025

Implementation of a Kidney Genetic Service Into the Diagnostic Pathway for Patients With Chronic Kidney Disease in Canada.

Schott C, Arnaldi M, Baker C, Wang J, McIntyre AD, Colaiacovo S, Relouw S, Offerni GA, Campagnolo C, Van Nynatten LR, Pourtousi A, Drago-Catalfo A, Lebedeva V, Chiu M, Cowan A, Filler G, Gunaratnam L, House AA, Huang S, Iyer H, Jain AK, Jevnikar AM, Lotfy K, Moist L, Rehman F, Roshanov PS, Sharma AP, Weir MA, Kidd K, Bleyer AJ, Hegele RA, Connaughton DM

Kidney Int Rep • 2025

Distinct peripheral pro-inflammatory profile associated with tuberous sclerosis complex and epilepsy.

Balthazard R, Drouin-Engler RM, Bertrand S, Zine-Eddine F, Li J, Tastet O, Daigneault A, Mamane VH, Ortega-Delgado GG, Sreng Flores AM, Kaufmann DE, Major P, House AA, Létourneau-Guillon L, Arbour N, Keezer MR, Larochelle C

Epilepsia • 2025

20242 items

Vascular calcification in chronic kidney disease associated with pathogenic variants in ABCC6.

Schott C, Dilliott AA, Wang J, McIntyre AD, Son S, Colaiacovo S, Baker C, Gunaratnam L, House AA, Susan Huang SH, Iyer H, Johnson J, Lotfy K, Masellis M, Munoz DP, Rehman F, Roshanov PS, Swartz RH, Weir MA, Hegele RA, Connaughton DM

Gene • 2024

Impact of Donation After Circulatory Death on Outcomes of Expanded Criteria Donor Kidney Transplants.

Alsolami E, Lotfy K, Alkhunaizi A, Cuerden M, Weir MA, House AA

Transplant Proc • 2024

20237 items

Risk and Timing of Major Bleeding Complications Requiring Intervention of the Percutaneous Kidney Biopsy With a Short Observation Protocol: A Retrospective Chart Review.

Schorr M, Roshanov PS, Vandelinde J, House AA

Can J Kidney Health Dis • 2023

Microscopic Kidney Disease in Tuberous Sclerosis Complex and Treatment With mTOR Inhibition.

Kronick J, Gabril MY, House AA

Am J Kidney Dis • 2023

Medical Management of Coronary Artery Disease in Patients with Chronic Kidney Disease.

Kim JA, Kim SE, El Hachem K, Virk HUH, Alam M, Virani SS, Sharma S, House A, Krittanawong C

Am J Med • 2023

Epidemiology and Outcomes of AKI Treated With Continuous Kidney Replacement Therapy: The Multicenter CRRTnet Study.

Rewa OG, Ortiz-Soriano V, Lambert J, Kabir S, Heung M, House AA, Monga D, Juncos LA, Secic M, Piazza R, Goldstein SL, Bagshaw SM, Neyra JA

Kidney Med • 2023

The effect of late-onset CMV infection on the outcome of renal allograft considering initial graft function.

Shahmirzadi MR, Gunaratnam L, Jevnikar AM, Luke P, House AA, Silverman MS, Hosseini-Moghaddam SM

Transpl Infect Dis • 2023

Investigation of N,N,N-Trimethyl-L-alanyl-L-proline Betaine (TMAP) as a Biomarker of Kidney Function.

Sidor NA, Velenosi TJ, Lajoie GA, Filler G, House AA, Weir MA, Thomson BK, Garg AX, Renaud JB, McDowell T, Knauer MJ, Tirona RG, Noble R, Selby N, Taal M, Urquhart BL

ACS Omega • 2023

Midodrine Is an Effective Therapy for Resistant Intradialytic Hypotension: PRO.

House AA, McIntyre CW

Kidney360 • 2023

← Back to team